miR-423-3p通过下调CARNS1促进乳腺癌细胞恶性生物学行为
miR-423-3p Promotes Malignant Biological Behavior in Breast Cancer Cells by Downregulating CARNS1
DOI: 10.12677/ACM.2024.143718, PDF,   
作者: 李金洋, 陈东旭, 傅腾超, 吴 琍*:青岛大学附属医院乳腺病诊疗中心,山东 青岛
关键词: 乳腺癌微小RNAmiR-423-3pCARNS1Breast Cancer microRNA miR-423-3p CARNS1
摘要: 目的:探讨miR-423-3p对乳腺癌细胞恶性生物学行为的影响及作用机制。方法:体外培养人乳腺癌细胞MDA-MB-231、MDA-MB-468、MCF-7、BT-549及正常乳腺上皮细胞MCF-10A,采用实时荧光定量PCR (RT-qPCR)法和Western Blot方法,分别检测miR-423-3p及CARNS1 mRNA和蛋白相对表达量。选取MCF-7细胞,将细胞分为转染mimics NC组(A组)、转染miR-423-3p mimics组(B组)、转染inhibitors NC组(C组)、转染inhibitors组(D组)。在239T细胞中分别转染并分为CARNS1-3'-UTR-wt+miR-423-3p mimics (E组)、CARNS1-3'-UTR-wt-mimics NC (F组)、CARNS1-3'-UTR-mut+miR-423-3p mimics (G组)及CARNS1-3'-UTR-mut+mimics NC (H组)。采用RT-qPCR和Western Blot法,检测A~D组细胞miR-423-3p及CARNS1 mRNA和蛋白表达情况,采用CCK8法、细胞划痕实验、Transwell法和流式细胞术检测细胞增殖、迁移、侵袭和凋亡情况。在线数据库预测miR-423-3p与CARNS1基因3'非翻译区(3'-UTR)的互补结合位点,双荧光素酶报告基因实验验证预测结果。结果:RT-qPCR结果显示,MCF-7、MDA-MB-231、MDA-MB-468及BT-549细胞中miR-423-3p的相对表达量均明显高于正常乳腺上皮细胞MCF-10A (P < 0.05),RT-qPCR和Western Blot检测结果显示,CARNS1 mRNA以及蛋白的相对表达量均明显低于正常乳腺上皮细胞MCF-10A (P < 0.05)。CCK8实验结果显示,在细胞培养的第24、48、72小时,B组细胞增殖活力明显高于A组,D组明显低于C组。细胞划痕实验显示,B组细胞愈合率明显高于A组(P < 0.05)。D组细胞愈合率明显低于C组(P < 0.05)。Transwell实验结果显示,过表达miR-423-3p后可促进乳腺癌细胞侵袭,而抑制miR-423-3p后会抑制乳腺癌细胞的侵袭,差异有统计学意义(P < 0.05)。流式细胞实验结果显示,B组较A组凋亡能力明显降低(P < 0.05),D组较C组凋亡能力明显增强(P < 0.05)。starBase数据库预测miR-423-3p与CARNS1基因3'非翻译区(3'-UTR)存在互补结合位点,双荧光素酶报告基因实验结果显示,E组较F组细胞相对荧光素酶显著下调(P < 0.05),G组与F组细胞间相对荧光素酶活性差异无统计学意义(P > 0.05)。RT-qPCR检测结果显示,B组细胞的miR-423-3p相对表达量明显高于A组(P < 0.05),而CARNS1 mRNA相对表达量明显低于A组(P < 0.05),D组细胞的miR-423-3p相对表达量明显低于C组(P < 0.05),而CARNS1 mRNA相对表达量明显高于C组(P < 0.05)。结论:miR-423-3p可通过靶向调控CARNS1促进乳腺癌细胞的恶性生物学行为。
Abstract: Objective: To investigate the effect and mechanism of miR-423-3p on the malignant biological be-havior of breast cancer cells. Methods: Human breast cancer cells MDA-MB-231, MDA-MB-468, MCF-7, BT-549 and normal breast epithelial cells MCF-10A were cultured in vitro, and the relative mRNA and protein expressions of miR-423-3p and CARNS1 were detected by real-time quantitative PCR (RT-qPCR) and Western Blot, respectively. MCF-7 cells were divided into mimics NC transfection group (group A), miR-423-3p mimics group (group B), transfection inhibitors NC group (group C), and transfection inhibitors group (group D). 239T cells were transfected and divided into CARNS1-3'-UTR-wt miR-423-3p mimics (group E), CARNS1-3'-UTR-wt-mimics NC (group F), CARNS1-3'-UTR-mut miR-423-3p mimics (group G) and CARNS1-3'-UTR-mut mimics NC (group H). The mRNA and protein expressions of miR-423-3p and CARNS1 in group A~D cells were detected by RT-qPCR and Western Blot, and the proliferation, migration, invasion and apoptosis of cells were detected by CCK8 method, cell scratch assay, Transwell method and flow cytometry. The comple-mentary binding sites of miR-423-3p and the 3 untranslated region (3'-UTR) of CARNS1 gene were predicted by an online database, and the prediction results were verified by double luciferase re-porter gene assays. Results: RT-qPCR results showed that the relative expression levels of miR-423-3p in MCF-7, MDA-MB-231, MDA-MB-468 and BT-549 cells were significantly higher than those in normal mammary epithelial cells MCF-10A (P < 0.05), and the relative expression levels of mRNA and protein in CARNS1 were significantly lower than those in normal mammary epithelial cells (P < 0.05). The results of CCK8 experiments showed that at the 24th, 48th and 72nd hours of cell culture, the cell proliferation activity of group B was significantly higher than that of group A, and that of group D was significantly lower than that of group C. The cell scratch test showed that the cell healing rate of group B was significantly higher than that of group A (P < 0.05). The cell healing rate of group D was significantly lower than that of group C (P < 0.05). The results of Transwell assay showed that overexpression of miR-423-3p could promote the invasion of breast cancer cells, while inhibition of miR-423-3p would inhibit the invasion of breast cancer cells, and the difference was statistically significant (P < 0.05). The results of flow cytometry showed that the apoptosis ability of group B was significantly lower than that of group A (P < 0.05), and the apopto-sis ability of group D was significantly higher than that of group C (P < 0.05). The starBase database predicted that miR-423-3p had complementary binding sites in the 3' untranslated region (3'-UTR) of CARNS1 gene, and the results of double luciferase reporter gene assay showed that the relative luciferase of group E was significantly down-regulated compared with group F (P < 0.05), and there was no significant difference in relative luciferase activity between group G and group F (P > 0.05). The results of RT-qPCR showed that the relative expression of miR-423-3p in group B was signifi-cantly higher than that in group A (P < 0.05), while the relative expression of mRNA in CARNS1 was significantly lower than that in group A (P < 0.05), the relative expression of miR-423-3p in group D was significantly lower than that in group C (P < 0.05), and the relative expression of mRNA in CARNS1 was significantly higher than that in group C (P < 0.05). Conclusion: miR-423-3p can pro-mote the malignant biological behavior of breast cancer cells by targeting CARNS1.
文章引用:李金洋, 陈东旭, 傅腾超, 吴琍. miR-423-3p通过下调CARNS1促进乳腺癌细胞恶性生物学行为[J]. 临床医学进展, 2024, 14(3): 415-423. https://doi.org/10.12677/ACM.2024.143718

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Murugesan, M. and Premkumar, K. (2021) Integrative miRNA-mRNA Functional Analysis Identifies miR-182 as a Potential Prognostic Biomarker in Breast Cancer. Molecular Omics, 17, 533-543. [Google Scholar] [CrossRef
[3] An, M., Zang, X., Wang, J., et al. (2021) Comprehensive Analysis of Differentially Expressed Long Noncoding RNAs, miRNAs and mRNAs in Breast Cancer Brain Metastasis. Epigenomics, 13, 1113-1128. [Google Scholar] [CrossRef] [PubMed]
[4] He, B., Zhao, Z., Cai, Q., et al. (2020) miRNA-Based Biomarkers, Therapies, and Resistance in Cancer. International Journal of Biological Sciences, 16, 2628-2647. [Google Scholar] [CrossRef] [PubMed]
[5] Ma, J., Huang, W., Zhu, C., et al. (2021) MiR-423-3p Activates FAK Sig-naling Pathway to Drive EMT Process and Tumor Growth in Lung Adenocarcinoma through Targeting CYBRD1. Journal of Clinical Laboratory Analysis, 35, E24044. [Google Scholar] [CrossRef] [PubMed]
[6] 赵楠, 张涛, 魏东, 等. MiR-423-3p通过靶向SUFU调节结肠癌细胞对5-Fu的敏感性[J]. 中国组织化学与细胞化学杂志, 2021, 30(2): 152-158.
[7] Xu, J., He, J., Huang, H., et al. (2018) MicroRNA-423-3p Promotes Glioma Growth by Targeting PANX2. Oncology Letters, 16, 179-188. [Google Scholar] [CrossRef] [PubMed]
[8] Loibl, S., Poortmans, P., Mor-row, M., et al. (2021) Breast Cancer. The Lancet, 397, 1750-1769. [Google Scholar] [CrossRef
[9] Fridrichova, I. and Zmetakova, I. (2019) MicroRNAs Con-tribute to Breast Cancer Invasiveness. Cells, 8, Article No. 1361. [Google Scholar] [CrossRef] [PubMed]
[10] Petri, B.J. and Klinge, C.M. (2020) Regulation of Breast Cancer Metastasis Signaling by miRNAs. Cancer and Metastasis Re-views, 39, 837-886. [Google Scholar] [CrossRef] [PubMed]
[11] Song, M., Liu, J., Zheng, X., et al. (2021) MiR-148a-3p Targets CEMIP to Suppress the Genesis of Gastric Cancer Cells.Biochemical and Biophysical Research Communications, 575, 42-49. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, W., Dong, J., Wang, M., et al. (2018) MiR-148a-3p Suppresses Epithelial Ovarian Cancer Progression Primarily by Targeting C-Met. Oncology Letters, 15, 6131-6136. [Google Scholar] [CrossRef] [PubMed]
[13] Iacona, J.R. and Lutz, C.S. (2019) MiR-146a-5p: Ex-pression, Regulation, and Functions in Cancer. Wiley Interdisciplinary Reviews: RNA, 10, E1533. [Google Scholar] [CrossRef] [PubMed]
[14] Liu, Y., Huang, R., Xie, D., et al. (2021) ZNF674-AS1 Antagonizes MiR-423-3p to Induce G0/G1 Cell Cycle Arrest in Non-Small Cell Lung Cancer Cells. Cell & Molecular Bio Letters, 26, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[15] Liu, Z. and Cui, Y. (2021) Bim’s Effect on the Expression of MiR-423-3p in Promoting Primary Hepatic Cancer (PHC) and Role of MiR-423-3p in PHC Proliferation and Invasion. Biochemical Genetics, 59, 1247-1259. [Google Scholar] [CrossRef] [PubMed]
[16] Guo, T., Wang, Y., Jia, J., et al. (2020) The Identification of Plasma Exosomal MiR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Develop-ment by Plasma Exosomal MiRNA Sequencing. Frontiers in Cell and Developmental Biology, 8, Article ID: 602493. [Google Scholar] [CrossRef] [PubMed]
[17] Yan, X., Zhang, S., Jia, J., et al. (2022) Exosomal MiR-423-3p In-hibits Macrophage M2 Polarization to Suppress the Malignant Progression of Cervical Cancer. Pathology—Research and Practice, 235, Article ID: 153882. [Google Scholar] [CrossRef] [PubMed]
[18] Drozak, J., Veiga-Da-Cunha, M., Vertommen, D., et al. (2010) Molecular Identification of Carnosine Synthase as ATP-Grasp Domain-Containing Protein 1 (ATPGD1). Journal of Bi-ological Chemistry, 285, 9346-9356. [Google Scholar] [CrossRef
[19] Artioli, G.G., Sale, C. and Jones, R.L. (2019) Carnosine in Health and Disease. European Journal of Sport Science, 19, 30-39. [Google Scholar] [CrossRef] [PubMed]
[20] Xiong, F., Mao, R., Zhao, R., et al. (2022) Plasma Exosomal S1PR5 and CARNS1 as Potential Non-Invasive Screening Biomarkers of Coronary Heart Disease. Frontiers in Cardi-ovascular Medicine, 9, Article ID: 845673. [Google Scholar] [CrossRef] [PubMed]
[21] Horii, Y., Shen, J., Fujisaki, Y., et al. (2012) Effects of L-Carnosine on Splenic Sympathetic Nerve Activity and Tumor Proliferation. Neuroscience Letters, 510, 1-5. [Google Scholar] [CrossRef] [PubMed]